» Articles » PMID: 33515086

Development and Validation of a CT-based Nomogram for Preoperative Prediction of Clear Cell Renal Cell Carcinoma Grades

Overview
Journal Eur Radiol
Specialty Radiology
Date 2021 Jan 30
PMID 33515086
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Nuclear grades are proved to be one of the most significant prognostic factors for clear cell renal cell carcinoma (ccRCC). Radiomics nomogram is a widely used noninvasive tool that could predict tumor phenotypes. In this study, we performed radiomics analysis to develop and validate a CT-based nomogram for the preoperative prediction of nuclear grades in ccRCC.

Method: CT images and clinical data of 258 ccRCC patients were retrieved from the Cancer Imaging Archive (TCIA). Radiomics features were extracted from arterial-phase CT images using 3D Slicer software. LASSO regression model was performed to develop a radiomics signature in the training set (n = 143). A radiomics nomogram was constructed combining radiomics signature and selected clinical predictors. Receiver operating characteristic (ROC) curve and calibration curve were used to determine the performance of the radiomics nomogram in the training and validation set (n = 115). Decision curve analysis was used to assess the clinical usefulness of the CT-based nomogram.

Results: One thousand three hundred sixteen radiomics features were extracted from arterial-phase CT images. A radiomics signature, consisting of 20 features, was developed and showed a favorable performance in discriminating nuclear grades with an area under the curve (AUC) of 0.914 and 0.846 in the training and validation set, respectively. The CT-based nomogram, including the radiomics signature and the CT-determined T stage, achieved good calibration and discrimination in the training set (AUC, 0.929; 95% CI, 0.886-0.972) and validation set (AUC, 0.876; 95% CI, 0.812-0.939). Decision curve analysis demonstrated the clinical usefulness of the CT-based nomogram.

Conclusion: The noninvasive CT-based nomogram, including radiomics signature and CT-determined T stage, could improve the accuracy of preoperative grading of ccRCC and provide individualized treatment for ccRCC patients.

Key Points: • Contrast-enhanced CT may help in preoperative grading of ccRCC. • The CT-based nomogram incorporated a radiomics signature and CT-determined T stage could preoperatively predict ccRCC grades. • The CT-based nomogram has the potential to improve individualized treatment and assist clinical decision making of ccRCC patients.

Citing Articles

Computed tomography-based delta-radiomics analysis for preoperative prediction of ISUP pathological nuclear grading in clear cell renal cell carcinoma.

Liu X, Han X, Zhang G, Zhu X, Zhang W, Wang X Abdom Radiol (NY). 2025; .

PMID: 40024922 DOI: 10.1007/s00261-025-04857-4.


CT-based scoring system for diagnosing eosinophilic solid and cystic renal cell carcinoma versus clear cell renal cell carcinoma.

Fu S, Chen D, Zhang Y, Wei Y, Pan Y Sci Rep. 2025; 15(1):2736.

PMID: 39838024 PMC: 11751170. DOI: 10.1038/s41598-025-86932-w.


Survival analysis of clear cell renal cell carcinoma based on radiomics and deep learning features from CT images.

Lu Z, Wu S, Ni D, Zhou M, Wang T, Zhou X Medicine (Baltimore). 2024; 103(51):e40723.

PMID: 39705434 PMC: 11666162. DOI: 10.1097/MD.0000000000040723.


Multiparameter computed tomography (CT) radiomics signature fusion-based model for the preoperative prediction of clear cell renal cell carcinoma nuclear grade: a multicenter development and external validation study.

Xv Y, Wei Z, Lv F, Jiang Q, Guo H, Zheng Y Quant Imaging Med Surg. 2024; 14(10):7031-7045.

PMID: 39429571 PMC: 11485359. DOI: 10.21037/qims-24-35.


Imaging in Renal Cell Carcinoma Detection.

Woon D, Qin S, Al-Khanaty A, Perera M, Lawrentschuk N Diagnostics (Basel). 2024; 14(18).

PMID: 39335784 PMC: 11431198. DOI: 10.3390/diagnostics14182105.


References
1.
Siegel R, Miller K, Jemal A . Cancer statistics, 2019. CA Cancer J Clin. 2019; 69(1):7-34. DOI: 10.3322/caac.21551. View

2.
Capitanio U, Montorsi F . Renal cancer. Lancet. 2015; 387(10021):894-906. DOI: 10.1016/S0140-6736(15)00046-X. View

3.
Dagher J, Delahunt B, Rioux-Leclercq N, Egevad L, Srigley J, Coughlin G . Clear cell renal cell carcinoma: validation of World Health Organization/International Society of Urological Pathology grading. Histopathology. 2017; 71(6):918-925. DOI: 10.1111/his.13311. View

4.
Moch H, Cubilla A, Humphrey P, Reuter V, Ulbright T . The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. Eur Urol. 2016; 70(1):93-105. DOI: 10.1016/j.eururo.2016.02.029. View

5.
Delahunt B, Eble J, Egevad L, Samaratunga H . Grading of renal cell carcinoma. Histopathology. 2018; 74(1):4-17. DOI: 10.1111/his.13735. View